We are live on ! Find out more
SCM

Silverarc Capital Management Portfolio holdings

AUM $849M
1-Year Est. Return 470.8%
This Fund
S&P 500
This Quarter Est. Return
+25.82%
1 Year Est. Return
+470.8%
3 Year Est. Return
+3,352.06%
5 Year Est. Return
+7,957.7%
10 Year Est. Return
–
AUM
$178M
AUM Growth
+$14.7M
Cap. Flow
+$16.6M
Cap. Flow %
9.31%
Top 10 Hldgs %
33.95%
Holding
106
New
24
Increased
27
Reduced
29
Closed
17

Top Buys

1
ODT
Odonate Therapeutics, Inc. Common Stock
ODT
+$9.45M
2
ACRS icon
Aclaris Therapeutics
ACRS
+$6.59M
3
MRUS
Merus
MRUS
+$5.65M
4
RACB
Research Alliance Corp. II Class A Common Stock
RACB
+$5.12M
5
MSACU
Medicus Sciences Acquisition Corp. Unit
MSACU
+$4.14M

Top Sells

1
VCEL icon
Vericel Corp
VCEL
+$7.21M
2
EPIX
ESSA Pharma
EPIX
+$5.8M
3
DCTH icon
Delcath Systems
DCTH
+$5.74M
4
STRO icon
Sutro Biopharma
STRO
+$4.02M
5
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$2.97M

Sector Composition

1 Healthcare 87.9%
2 Financials 3.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACRS icon
1
Aclaris Therapeutics
ACRS
$758M
$8.49M 4.75%
+336,737
New +$6.59M
CRIS icon
2
Curis
CRIS
$9.06M
$7.12M 3.99%
1,572
+247
+19% +$1.03M
VCEL icon
3
Vericel Corp
VCEL
$2.35B
$6.78M 3.8%
122,125
-159,221
-57% -$7.21M
INSM icon
4
Insmed
INSM
$23.9B
$6.5M 3.64%
190,810
+15,810
+9% +$604K
AMYT
5
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
$5.99M 3.36%
429,863
+27,307
+7% +$382K
IMGN
6
DELISTED
Immunogen Inc
IMGN
$5.91M 3.31%
729,364
+129,364
+22% +$1.06M
RACB
7
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
$5.13M 2.87%
+500,000
New +$5.12M
DRNA
8
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$5.11M 2.87%
200,000
-27,388
-12% -$700K
MRUS
9
DELISTED
Merus
MRUS
$5.11M 2.86%
+244,713
New +$5.65M
HZNP
10
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$4.46M 2.5%
48,476
+18,476
+62% +$1.56M
ITCI
11
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$4.42M 2.47%
130,117
-69,883
-35% -$2.42M
HALO icon
12
Halozyme
HALO
$8.9B
$4.38M 2.45%
104,945
+4,945
+5% +$226K
MSACU
13
DELISTED
Medicus Sciences Acquisition Corp. Unit
MSACU
$4.01M 2.25%
+406,791
New +$4.14M
AFMD
14
DELISTED
Affimed
AFMD
$3.97M 2.23%
50,233
+10,233
+26% +$664K
ALDX icon
15
Aldeyra Therapeutics
ALDX
$116M
$3.82M 2.14%
+321,879
New +$3.71M
MORF
16
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$3.8M 2.13%
60,000
+8,567
+17% +$393K
JNCE
17
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$3.6M 2.01%
350,000
-56,665
-14% -$621K
RNLX
18
DELISTED
Renalytix plc American Depositary Shares
RNLX
$3.45M 1.93%
134,555
-6,698
-5% -$168K
TCRR
19
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$3.43M 1.92%
155,145
+19,145
+14% +$522K
BHVN
20
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$3.42M 1.92%
50,089
+33,589
+204% +$2.72M
VCYT icon
21
Veracyte
VCYT
$4.52B
$3.23M 1.81%
+60,000
New +$3.46M
EYPT icon
22
EyePoint Inc
EYPT
$1.15B
$3.05M 1.71%
+300,000
New +$3.38M
VSTM icon
23
Verastem
VSTM
$489M
$2.96M 1.66%
99,791
+5,145
+5% +$144K
DCOY
24
Decoy Therapeutics
DCOY
$3.06M
$2.95M 1.65%
+55
New +$3.15M
CCXI
25
DELISTED
ChemoCentryx, Inc.
CCXI
$2.87M 1.61%
55,974
+2,208
+4% +$133K
1
2 3 4 5

Similar funds

BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
EFG
Embree Financial Group Chicago, Illinois $849M AUM 19.63% 1-Year Est. Return
LA
Legacy Advisors Plymouth Meeting, Pennsylvania $848M AUM 21.32% 1-Year Est. Return
EPIMS
Evelyn Partners Investment Management Services London $850M AUM 20.89% 1-Year Est. Return
CFP
Catalyst Financial Partners Boston, Massachusetts $847M AUM 29.19% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $846M AUM 32.1% 1-Year Est. Return
AIA
Absolute Investment Advisers Rosemary Beach, Florida $852M AUM 0.1% 1-Year Est. Return